UniProt ID | H2AX_HUMAN | |
---|---|---|
UniProt AC | P16104 | |
Protein Name | Histone H2AX | |
Gene Name | H2AFX | |
Organism | Homo sapiens (Human). | |
Sequence Length | 143 | |
Subcellular Localization | Nucleus . Chromosome . | |
Protein Description | Variant histone H2A which replaces conventional H2A in a subset of nucleosomes. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. Required for checkpoint-mediated arrest of cell cycle progression in response to low doses of ionizing radiation and for efficient repair of DNA double strand breaks (DSBs) specifically when modified by C-terminal phosphorylation.. | |
Protein Sequence | MSGRGKTGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGHYAERVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAIRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTSATVGPKAPSGGKKATQASQEY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSGRGKTGG ------CCCCCCCCC | 36.88 | 9488723 | |
6 | Acetylation | --MSGRGKTGGKARA --CCCCCCCCCHHHH | 42.51 | 19608861 | |
6 | Lactylation | --MSGRGKTGGKARA --CCCCCCCCCHHHH | 42.51 | 31645732 | |
10 | Lactoylation | GRGKTGGKARAKAKS CCCCCCCHHHHHHHH | 35.72 | - | |
10 | Lactylation | GRGKTGGKARAKAKS CCCCCCCHHHHHHHH | 35.72 | 31645732 | |
10 | Acetylation | GRGKTGGKARAKAKS CCCCCCCHHHHHHHH | 35.72 | 26051181 | |
14 | Ubiquitination | TGGKARAKAKSRSSR CCCHHHHHHHHHHHC | 51.28 | 22980979 | |
16 | Acetylation | GKARAKAKSRSSRAG CHHHHHHHHHHHCCC | 45.77 | 19666589 | |
16 | Ubiquitination | GKARAKAKSRSSRAG CHHHHHHHHHHHCCC | 45.77 | 22980979 | |
17 | Phosphorylation | KARAKAKSRSSRAGL HHHHHHHHHHHCCCC | 42.10 | 24247654 | |
19 | Phosphorylation | RAKAKSRSSRAGLQF HHHHHHHHHCCCCCC | 31.13 | 30622161 | |
20 | Phosphorylation | AKAKSRSSRAGLQFP HHHHHHHHCCCCCCC | 25.66 | 27966365 | |
21 | Methylation | KAKSRSSRAGLQFPV HHHHHHHCCCCCCCH | 33.64 | - | |
30 | Methylation | GLQFPVGRVHRLLRK CCCCCHHHHHHHHHC | 22.69 | - | |
37 | Acetylation | RVHRLLRKGHYAERV HHHHHHHCCCHHHHC | 50.43 | - | |
40 | Phosphorylation | RLLRKGHYAERVGAG HHHHCCCHHHHCCCC | 20.87 | 22817900 | |
58 | Phosphorylation | YLAAVLEYLTAEILE HHHHHHHHHHHHHHH | 12.75 | - | |
77 | Phosphorylation | AARDNKKTRIIPRHL HHHCCCCCCEEHHHH | 28.80 | 23882029 | |
82 | Methylation | KKTRIIPRHLQLAIR CCCCEEHHHHHHHHC | 32.51 | - | |
89 | Methylation | RHLQLAIRNDEELNK HHHHHHHCCHHHHHH | 38.65 | - | |
96 | Ubiquitination | RNDEELNKLLGGVTI CCHHHHHHHHCCEEE | 58.68 | 22817900 | |
96 | Acetylation | RNDEELNKLLGGVTI CCHHHHHHHHCCEEE | 58.68 | 25038526 | |
102 | O-linked_Glycosylation | NKLLGGVTIAQGGVL HHHHCCEEEECCCCC | 17.55 | 27458206 | |
102 | Phosphorylation | NKLLGGVTIAQGGVL HHHHCCEEEECCCCC | 17.55 | 20703100 | |
119 | Ubiquitination | IQAVLLPKKTSATVG EEEEECCCCCCCCCC | 69.52 | 25015289 | |
119 | Sumoylation | IQAVLLPKKTSATVG EEEEECCCCCCCCCC | 69.52 | - | |
119 | Neddylation | IQAVLLPKKTSATVG EEEEECCCCCCCCCC | 69.52 | 32015554 | |
119 | Acetylation | IQAVLLPKKTSATVG EEEEECCCCCCCCCC | 69.52 | 164041 | |
120 | Neddylation | QAVLLPKKTSATVGP EEEECCCCCCCCCCC | 45.86 | 32015554 | |
120 | Ubiquitination | QAVLLPKKTSATVGP EEEECCCCCCCCCCC | 45.86 | 23000965 | |
120 | Lactylation | QAVLLPKKTSATVGP EEEECCCCCCCCCCC | 45.86 | 31645732 | |
121 | Phosphorylation | AVLLPKKTSATVGPK EEECCCCCCCCCCCC | 29.71 | 30266825 | |
122 | Phosphorylation | VLLPKKTSATVGPKA EECCCCCCCCCCCCC | 30.72 | 30266825 | |
124 | Phosphorylation | LPKKTSATVGPKAPS CCCCCCCCCCCCCCC | 26.26 | 30266825 | |
128 | Lactylation | TSATVGPKAPSGGKK CCCCCCCCCCCCCHH | 67.98 | 31645732 | |
128 | Ubiquitination | TSATVGPKAPSGGKK CCCCCCCCCCCCCHH | 67.98 | 32142685 | |
128 | Sumoylation | TSATVGPKAPSGGKK CCCCCCCCCCCCCHH | 67.98 | 28112733 | |
131 | Phosphorylation | TVGPKAPSGGKKATQ CCCCCCCCCCHHCCH | 66.10 | 26074081 | |
134 | "N6,N6-dimethyllysine" | PKAPSGGKKATQASQ CCCCCCCHHCCHHHH | 42.64 | - | |
134 | Acetylation | PKAPSGGKKATQASQ CCCCCCCHHCCHHHH | 42.64 | 26051181 | |
134 | Methylation | PKAPSGGKKATQASQ CCCCCCCHHCCHHHH | 42.64 | - | |
134 | Ubiquitination | PKAPSGGKKATQASQ CCCCCCCHHCCHHHH | 42.64 | 27667366 | |
135 | Methylation | KAPSGGKKATQASQE CCCCCCHHCCHHHHC | 61.00 | - | |
135 | Acetylation | KAPSGGKKATQASQE CCCCCCHHCCHHHHC | 61.00 | 26051181 | |
135 | Lactylation | KAPSGGKKATQASQE CCCCCCHHCCHHHHC | 61.00 | 31645732 | |
135 | Sumoylation | KAPSGGKKATQASQE CCCCCCHHCCHHHHC | 61.00 | 28112733 | |
135 | Ubiquitination | KAPSGGKKATQASQE CCCCCCHHCCHHHHC | 61.00 | 21906983 | |
137 | Phosphorylation | PSGGKKATQASQEY- CCCCHHCCHHHHCC- | 33.28 | 28176443 | |
140 | O-linked_Glycosylation | GKKATQASQEY---- CHHCCHHHHCC---- | 17.46 | 27458206 | |
140 | Phosphorylation | GKKATQASQEY---- CHHCCHHHHCC---- | 17.46 | 21151168 | |
140 | Dephosphorylation | GKKATQASQEY---- CHHCCHHHHCC---- | 17.46 | 12926989 | |
143 | Phosphorylation | ATQASQEY------- CCHHHHCC------- | 19.06 | 28176443 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
16 | S | Phosphorylation | Kinase | RSK2 | P51812 | PSP |
17 | S | Phosphorylation | Kinase | RPS6KA3 | P51812 | GPS |
39 | Y | Phosphorylation | Kinase | JMJD6 | Q6NYC1 | PSP |
57 | Y | Phosphorylation | Kinase | CK2A1 | P68400 | PSP |
136 | T | Phosphorylation | Kinase | PRKDC | P78527 | GPS |
139 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
139 | S | Phosphorylation | Kinase | PRKDC | P78527 | GPS |
139 | S | Phosphorylation | Kinase | STK4 | Q13043 | GPS |
140 | S | Phosphorylation | Kinase | ATM | Q13315 | Uniprot |
140 | S | Phosphorylation | Kinase | ATR | Q13535 | Uniprot |
140 | S | Phosphorylation | Kinase | RPS6KA3 | P51812 | GPS |
140 | S | Phosphorylation | Kinase | PRKDC | P78527 | Uniprot |
142 | Y | Phosphorylation | Kinase | BAZ1B | Q9UIG0 | GPS |
143 | Y | Phosphorylation | Kinase | WSTF | Q9UIG0 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | BMI1 | P35226 | PMID:21676867 |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF2 | Q99496 | PMID:21676867 |
- | K | Ubiquitination | E3 ubiquitin ligase | TOPORS | Q9NS56 | PMID:22972498 |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF8 | O76064 | PMID:18001824 |
- | K | Ubiquitination | E3 ubiquitin ligase | BRCA1 | P38398 | PMID:11927591 |
- | K | Ubiquitination | E3 ubiquitin ligase | BARD1 | Q99728 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | PRC1 | O43663 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF168 | Q8IYW5 | PMID:22980979 |
- | K | Ubiquitination | E3 ubiquitin ligase | BMI1#RNF2 | P35226#Q99496 | PMID:22199232 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
14 | K | ubiquitylation |
| 22980979 |
16 | K | ubiquitylation |
| 22980979 |
37 | K | Acetylation |
| - |
63 | K | ubiquitylation |
| 18001824 |
120 | K | ubiquitylation |
| 18001824 |
140 | S | Phosphorylation |
| 9488723 |
140 | S | Phosphorylation |
| 9488723 |
140 | S | Phosphorylation |
| 9488723 |
140 | S | Phosphorylation |
| 9488723 |
140 | S | Phosphorylation |
| 9488723 |
140 | S | Phosphorylation |
| 9488723 |
140 | S | Phosphorylation |
| 9488723 |
140 | S | Phosphorylation |
| 9488723 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of H2AX_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6 AND LYS-10, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND MASSSPECTROMETRY. | |
"Actinomycin D induces histone gamma-H2AX foci and complex formationof gamma-H2AX with Ku70 and nuclear DNA helicase II."; Mischo H.E., Hemmerich P., Grosse F., Zhang S.; J. Biol. Chem. 280:9586-9594(2005). Cited for: INTERACTION WITH DHX9, SUBCELLULAR LOCATION, AND PHOSPHORYLATION ATSER-140. | |
"Doxorubicin activates ATM-dependent phosphorylation of multipledownstream targets in part through the generation of reactive oxygenspecies."; Kurz E.U., Douglas P., Lees-Miller S.P.; J. Biol. Chem. 279:53272-53281(2004). Cited for: PHOSPHORYLATION AT SER-140. | |
"ATM and DNA-PK function redundantly to phosphorylate H2AX afterexposure to ionizing radiation."; Stiff T., O'Driscoll M., Rief N., Iwabuchi K., Loebrich M.,Jeggo P.A.; Cancer Res. 64:2390-2396(2004). Cited for: SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-140. | |
"DNA-PK is activated by nucleosomes and phosphorylates H2AX within thenucleosomes in an acetylation-dependent manner."; Park E.-J., Chan D.W., Park J.-H., Oettinger M.A., Kwon J.; Nucleic Acids Res. 31:6819-6827(2003). Cited for: PHOSPHORYLATION AT SER-140. | |
"MDC1 is a mediator of the mammalian DNA damage checkpoint."; Stewart G.S., Wang B., Bignell C.R., Taylor A.M.R., Elledge S.J.; Nature 421:961-966(2003). Cited for: FUNCTION, INTERACTION WITH MDC1 AND TP53BP1, SUBCELLULAR LOCATION, ANDPHOSPHORYLATION AT SER-140. | |
"Phosphorylation of histone H2AX and activation of Mre11, Rad50, andNbs1 in response to replication-dependent DNA double-strand breaksinduced by mammalian DNA topoisomerase I cleavage complexes."; Furuta T., Takemura H., Liao Z.-Y., Aune G.J., Redon C.,Sedelnikova O.A., Pilch D.R., Rogakou E.P., Celeste A., Chen H.T.,Nussenzweig A., Aladjem M.I., Bonner W.M., Pommier Y.; J. Biol. Chem. 278:20303-20312(2003). Cited for: SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-140. | |
"Accumulation of checkpoint protein 53BP1 at DNA breaks involves itsbinding to phosphorylated histone H2AX."; Ward I.M., Minn K., Jorda K.G., Chen J.; J. Biol. Chem. 278:19579-19582(2003). Cited for: SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-140. | |
"NBS1 localizes to gamma-H2AX foci through interaction with theFHA/BRCT domain."; Kobayashi J., Tauchi H., Sakamoto S., Nakamura A., Morishima K.,Matsuura S., Kobayashi T., Tamai K., Tanimoto K., Komatsu K.; Curr. Biol. 12:1846-1851(2002). Cited for: FUNCTION, INTERACTION WITH NBN AND BRCA1, SUBCELLULAR LOCATION, ANDPHOSPHORYLATION AT SER-140. | |
"Histone H2AX is phosphorylated in an ATR-dependent manner in responseto replicational stress."; Ward I.M., Chen J.; J. Biol. Chem. 276:47759-47762(2001). Cited for: SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-140. | |
"Initiation of DNA fragmentation during apoptosis inducesphosphorylation of H2AX histone at serine 139."; Rogakou E.P., Nieves-Neira W., Boon C., Pommier Y., Bonner W.M.; J. Biol. Chem. 275:9390-9395(2000). Cited for: PHOSPHORYLATION AT SER-140. | |
"A critical role for histone H2AX in recruitment of repair factors tonuclear foci after DNA damage."; Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M.,Bonner W.M.; Curr. Biol. 10:886-895(2000). Cited for: FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-140. | |
"Megabase chromatin domains involved in DNA double-strand breaks invivo."; Rogakou E.P., Boon C., Redon C., Bonner W.M.; J. Cell Biol. 146:905-916(1999). Cited for: SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-140. | |
"DNA double-stranded breaks induce histone H2AX phosphorylation onserine 139."; Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M.; J. Biol. Chem. 273:5858-5868(1998). Cited for: PHOSPHORYLATION AT SER-140, AND MUTAGENESIS OF GLN-141. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-121, AND MASSSPECTROMETRY. | |
"Tyrosine dephosphorylation of H2AX modulates apoptosis and survivaldecisions."; Cook P.J., Ju B.G., Telese F., Wang X., Glass C.K., Rosenfeld M.G.; Nature 458:591-596(2009). Cited for: PHOSPHORYLATION AT TYR-143, AND MUTAGENESIS OF TYR-143. | |
"WSTF regulates the H2A.X DNA damage response via a novel tyrosinekinase activity."; Xiao A., Li H., Shechter D., Ahn S.H., Fabrizio L.A.,Erdjument-Bromage H., Ishibe-Murakami S., Wang B., Tempst P.,Hofmann K., Patel D.J., Elledge S.J., Allis C.D.; Nature 457:57-62(2009). Cited for: PHOSPHORYLATION AT TYR-143, AND MUTAGENESIS OF TYR-143. |